Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Forced Transdifferentiation

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of genomic sequencing information on physicians' treatment recommendations for children with congenital heart disease.

Genetics in medicine open·2025

Same author

Disentangling informing participants from obtaining their consent.

Learning health systems·2025

Same author

Toward a framework for risk mitigation of potential misuse of artificial intelligence in biomedical research.

Nature machine intelligence·2025

Same author

A Qualitative Analysis of Physician Communication During Brain Death Conversations: Dead With a Heartbeat.

Neurology. Clinical practice·2025

Same author

Exploring How Claims of "Suffering" are Operationalized in Pediatric Critical Care.

Journal of pain and symptom management·2025

Same author

Asilomar Revisited.

The American journal of bioethics : AJOB·2025

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Using Cleavage Under Targets and Tagmentation (CUT&Tag) Assay in Mouse Myoblast Research

Using Cleavage Under Targets and Tagmentation (CUT&Tag) Assay in Mouse Myoblast Research

Published on: March 1, 2024

Translating stem cell research: challenges at the research frontier.

¹Stanford University, USA.

The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics

|June 29, 2010

Summary

This study examines translating basic stem cell research into clinical applications, focusing on novel human embryonic stem cell (hESC) trials. It highlights that ethical challenges primarily emerge in frontier research, not established stem cell therapies.

More Related Videos

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Related Experiment Videos

Last Updated: Jun 12, 2026

Using Cleavage Under Targets and Tagmentation (CUT&Tag) Assay in Mouse Myoblast Research

Using Cleavage Under Targets and Tagmentation (CUT&Tag) Assay in Mouse Myoblast Research

Published on: March 1, 2024

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Area of Science:

Biomedical Research
Translational Science
Clinical Ethics

Background:

Established stem cell practices like bone marrow transplantation are distinct from emerging clinical trials.
Focus is on novel applications, particularly those involving human embryonic stem cell (hESC)-derived stem cells.
Distinguishing between standard research and frontier research is crucial for ethical considerations.

Purpose of the Study:

To analyze the translation of basic stem cell research into clinical settings.
To identify and discuss the ethical challenges inherent in early-stage stem cell clinical trials.
To differentiate ethical considerations in frontier stem cell research versus established practices.

Main Methods:

Literature review and ethical analysis of current stem cell research translation.
Case study approach focusing on human embryonic stem cell (hESC) derived stem cell trials.
Comparative analysis of ethical frameworks for established vs. frontier stem cell research.

Main Results:

Ethical challenges are significantly more pronounced in frontier stem cell research.
Human embryonic stem cell (hESC) derived stem cell trials present unique ethical considerations.
Established stem cell procedures have well-defined ethical protocols, unlike novel approaches.

Conclusions:

The translation of basic stem cell research into clinical practice requires careful ethical navigation, especially for novel therapies.
Ethical oversight must adapt to the unique challenges posed by emerging stem cell technologies like those derived from hESCs.
Future research should prioritize developing robust ethical guidelines for frontier stem cell clinical trials.